A new technique may reprogram immune cells inside the body, offering faster, simpler, and more accessible cancer treatment.

bCancer-fighting immune cells may soon be engineered directly inside the body, removing the need for complex lab-based manufacturing./b Researchers

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors,...

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity &...

Creative Biolabs expands its immunotherapy portfolio, offering GMP-grade products and viral vector solutions to streamline clinical CAR-T cell therapy...

The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumours that have...

Loran Geddes, 29, says she feels like the healthcare system in New Zealand has failed her and her family.

Liver cancer in children is rare, but when it occurs, the two main types are hepatoblastoma (HB) and hepatocellular carcinoma (HCC). In some cases,...

"TIGIT Inhibitor Clinical Trial" TIGIT Inhibitor Companies include Genentech, BeiGene, Arcus Biosciences, iTeos Therapeutics, Merck KGaA, Curocell,...